RebeccaElstromMD
Hematology • San Francisco, CAVice President, Clinical Development, Fate Therapeutics
Dr. Elstrom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
706 Faxon Ave
San Francisco, CA 94112Phone+1 267-249-8265
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
Emory University School of MedicineResidency, Internal Medicine, 1996 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
CA State Medical License 2013 - 2025
NY State Medical License 2007 - 2013
MI State Medical License 2005 - 2009
PA State Medical License 1999 - 2006
GA State Medical License 1997 - 1999
Publications & Presentations
PubMed
- 821 citationsTargeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaWyndham H. Wilson, Ryan M. Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga
Nature Medicine. 2015-07-20 - 320 citationsUtility of FDG-PET scanning in lymphoma by WHO classificationRebecca Elstrom, Liang Guan, Gary Baker, Khozaim Nakhoda, Jo-Anne Vergilio
Blood. 2003-05-15 - 259 citationsOutcome of Deferred Initial Therapy in Mantle-Cell LymphomaPeter Martin, Amy Chadburn, Paul J. Christos, Karen Weil, Richard R. Furman
Journal of Clinical Oncology. 2009-03-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
